GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Change in Receivables (2009 - 2023)

Updated

Gsk's Change in Receivables came in at -$985.47 million for the quarter ended Dec 31, 2023, compared with -$185.32 million a year earlier.

Analysis

Gsk (GSK) Change in Receivables (2009 - 2023) Analysis & Trends

For the year ended Dec 31, 2023, Gsk's Change in Receivables was -$987.6 million.

  • Going back by year, Change in Receivables was -$195.54 million in the year ended Dec 31, 2022 and -$1.07 billion in the year ended Dec 31, 2021.
  • The figure for the quarter ended Dec 31, 2023 represents the lowest quarterly Change in Receivables since the quarter ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn -
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn -188.00 Mn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn 1.37 Bn
4 Merck 370.60 Bn 370.60 Bn - -
5 Novartis Ag 311.97 Bn 285.20 Bn - -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn -
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn - -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn -
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -985.47 Mn
Dec 31, 2022 -185.32 Mn
Dec 31, 2021 -1.05 Bn
Dec 31, 2012 293.87 Mn
Dec 31, 2011 301.74 Mn
Dec 31, 2010 1.43 Bn
Dec 31, 2009 -772.64 Mn
API Access

Gsk Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GSK&period=max&api_key=YOUR_API_KEY